Albert Einstein Healthcare Network

Open enrollment with a later-stage pipeline tilt

According to ClinicalTrials.gov-derived indexes, Albert Einstein Healthcare Network sits in the top decile of US sponsors by registered trial count (#386 of 15,742 sponsors by registered trial count).

48 total trials 3 currently recruiting 28 completed later-stage tilt top decile by trial count

Albert Einstein Healthcare Network: 48 sponsored US clinical trials, 3 recruiting.

Albert Einstein Healthcare Network sponsors 48 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 28 completed. 7 of these trials are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Traumatic Brain Injury, with 2 trials.

Top-decile sponsor footprint

Albert Einstein Healthcare Network ranks in the top decile of sponsors by registered trial count (#386 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

F 6/100

28 of 42 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (66.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

48 total, page 1 of 1

RECRUITING NA

Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain.Home-Based Treatment

NCT07044323
RECRUITING NA

Unlocking Movement Potential: Enhancing Parkinson's Disease Treatment With Robotic EksoSkeleton

NCT06225830
RECRUITING NA

GetUp&Go: A Randomized Controlled Trial of an Intervention to Enhance Physical Activity After TBI

NCT06028334
ACTIVE NOT RECRUITING NA

Motor Learning After Cerebellar Damage: The Role of the Primary Motor Cortex

NCT05351255
ACTIVE NOT RECRUITING Phase 2

Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

NCT03386305
NOT YET RECRUITING NA

Effects of Semantic Context on Criterion-learning Naming Treatment in Aphasia

NCT07673198
COMPLETED NA

Criterion-learning Based Naming Treatment in Aphasia

NCT06364709
COMPLETED NA

Assessing an Animal-Assisted Treatment Program for Adults With Aphasia: The Persons With Aphasia Training Dogs Program

NCT04610346
COMPLETED NA

Speech Entrainment Treatment for People With Aphasia

NCT05687994
COMPLETED NA

Efficacy and Mechanisms of Virtual Reality Treatment of Phantom Leg Pain

NCT05296265
COMPLETED NA

Aesthetic Effect of Steri-Strip Orientation on Healing and Scar Appearance in Breast Surgery

NCT04554316
TERMINATED NA

Health Literacy Activation RCT Among the COPD Patients and Designated Support Dyad

NCT03721315
COMPLETED Early Phase 1

Perceptual-motor Interaction to Improve Bimanual Coordination After Stroke

NCT03755076
TERMINATED

Initiative to Minimize Disparities in Postoperative Prostate Cancer Care

NCT03755492
COMPLETED NA

Introducing Palliative Care (PC) Within the Treatment of End Stage Liver Disease (ESLD)

NCT03540771
TERMINATED NA

Reducing Emergency Department Visits and Improving Glucose Control in Uncontrolled Type 2 Diabetes Using CGM Sensors at Hospital Discharge

NCT04277780
COMPLETED Phase 4

Assessment of Gait After Dysport Treatment

NCT03501043
TERMINATED NA

Telemedicine for Improving Outcome in Inner City Patient Population With Hypercapneic Respiratory Failure

NCT03353064
COMPLETED NA

Auto-PAP for Pulmonary Hypertension Treatment in Decompensated HF Patients With Sleep Apnea.

NCT02963597
TERMINATED NA

Adjunctive Nitrous Oxide During ED Incision and Drainage of Abscess

NCT03127371
TERMINATED NA

Shear Wave Elastography in Native Kidney Disease

NCT02830438
COMPLETED

Can Rivaroxaban Lead to Anticoagulation-Related Nephropathy?

NCT02900170
COMPLETED NA

Monitoring of Symptoms and Cognitive Function Using Telehealth

NCT03184701
COMPLETED NA

Adjunctive Nitrous Oxide During Emergency Department Propofol Sedation in Adults

NCT02410707
TERMINATED

Change In Diaphragmatic Thickness Predicts Extubation Success

NCT02656199
COMPLETED

Bicycle Exercise Echocardiography to Assess Physiological Significance of Mitral Annular Calcification

NCT04093973
COMPLETED NA

A Comparison of Inhalation vs. Intravenous Induction

NCT02331108
TERMINATED NA

Low-dose Propofol for the Treatment of Severe Refractory Migraine Headache in the Emergency Department

NCT02492295
COMPLETED NA

SMS Messaging to Reduce Depression and Anxiety Following TBI

NCT02061553
COMPLETED NA

Inhaled Nitrous Oxide for the Prevention of Emergence Reaction During Ketamine Administration in Adults, a Pilot Study

NCT02145169
TERMINATED Phase 4

Silodosin Versus Tamsulosin for Treatment of Ureteral Stones

NCT02369744
COMPLETED NA

Comparison of the Functional Walking Outcomes of Two Settings of a Commercially Available AFO in Adult Stroke Patients

NCT02122783
COMPLETED NA

Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke

NCT01662960
COMPLETED NA

Anger Self-Management in Traumatic Brain Injury

NCT01745146
COMPLETED NA

Use of a Single Dose of Oral Prednisone in the Treatment of Cellulitis

NCT01671423
TERMINATED Phase 4

Vapocoolant Spray for Numbing Small Boils Before Incision and Drainage

NCT01673061
COMPLETED NA

What to Eat for Lunch? A Pilot Study to Improve Healthier Eating at Work

NCT01674751
TERMINATED NA

Study of Respiratory Depression When Using a Hydromorphone Pain Protocol

NCT01784991
COMPLETED NA

The Use of Incentives to Promote Healthier Eating in Low-income Communities

NCT01616628
TERMINATED Phase 4

Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine

NCT01629329
TERMINATED

Use of Amplified Sound Signal to Identify Presence of Carotid and Femoral Stenosis

NCT01599195
COMPLETED NA

Use of Platelet Rich Plasma Therapy for Acute Ankle Sprains in the Emergency Department

NCT01518335
COMPLETED Phase 4

Treatment of Sleep Disordered Breathing In Acute Decompensated Heart Failure Patients

NCT00804349
COMPLETED NA

Short Term Hemodynamic Effects of Controlled Slow Breathing With Biofeedback in Patients With Heart Failure

NCT00971386
COMPLETED

Study of Left Ventricular Dyssynchrony in Heart Failure Patients

NCT00953953
COMPLETED Phase 4

Mycophenolate Mofetil Immunosuppression Without/With Reduced Dose Calcineurin Inhibitor Long After Liver Transplantation

NCT00206076
TERMINATED NA

Active Management Of Risk In Pregnancy At Term to Reduce Rate of Cesarean Deliveries

NCT00598260
COMPLETED Phase 3

Octreotide for the Treatment of Sulfonylurea-Associated Hypoglycemia

NCT00804297

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1
Phase 3 1
Phase 4 6

Therapeutic Areas

Traumatic Brain Injury 2
Healthier Eating in Low-income Communities 1
Focus of the Study is on the Use of Incentives to Promote 1
Perianal Abscess 1
Joint Dislocation 1
Cellulitis 1
Abscess 1
Post Liver Transplant 1
Cerebellar Ataxia 1
Phantom Pain Following Amputation of Lower Limb 1

Where Albert Einstein Healthcare Network enrollment is open (later-stage tilt)

3 recruiting of 48 indexed (6% open); 28 completed (58%).

Phase mix: 7 late (III/IV) vs 2 early (I/II) (later-stage heavy).

Top condition: Traumatic Brain Injury (2 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Albert Einstein Healthcare Network: open-pipeline peers nationwide

Peers matched on 48 registered trials and 6% open enrollment, not the therapeutic-area sidebar.

Albert Einstein Healthcare Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 102030405060 0%10%20%30% Total trials Recruiting share Albert Einstein Healthcare NetworkExelixisSun Pharmaceutical IndustriesWalter Reed National Military Medical CenterAlnylam PharmaceuticalsAltimmuneBassett HealthcareDynavax Technologies CorporationEast Tennessee State University
Albert Einstein Healthcare Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Albert Einstein Healthcare Network sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 48 trials (± recruiting share)

Sponsors near 6% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Albert Einstein Healthcare Network page

48 registered trials is a research-attention snapshot, not an endorsement of Albert Einstein Healthcare Network or any single study.

  • 3 of Albert Einstein Healthcare Network's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Traumatic Brain Injury is the condition Albert Einstein Healthcare Network studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Traumatic Brain Injury trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Albert Einstein Healthcare Network pipeline card: 48 registered trials from official public datasets.Report a data error.